TNBC is the most malignant subtype of breast cancer accounting for approximately 15% of all breast cancers without expressions of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to breast carcinoma.